CRNX
Crinetics Pharmaceuticals, Inc.$37.99-0.63 (-1.63%)Prev Close$38.62·MCap$4.01B·P/E—·Vol1.31M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
15
$11.27M
◆
Net Activity
Net Seller
$11.27M
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at Crinetics Pharmaceuticals, Inc. (CRNX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 15 insider sales totaling $11.27M. The most recent insider transaction was by Knight Jeff E. (officer: Chief Dev. & Operating Officer), who sold $3.42M worth of shares on Apr 10, 2026. Crinetics Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $4.01B.
CRNX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 10, 2026 | Knight Jeff E. | officer: Chief Dev. & Operating Officer | Sell | 85,163 | $40.10 | $3.42M | 105,289-45% |
| Mar 18, 2026 | Betz Stephen F. | officer: Chief Scientific Officer | Sell | 10,612 | $37.37 | $396.6K | 141,342 |
| Mar 18, 2026 | Knight Jeff E. | officer: Chief Operating Officer | Sell | 9,911 | $37.37 | $370.4K | 115,979 |
| Mar 18, 2026 | Struthers Richard Scott | director, officer: President & CEO | Sell | 21,981 | $37.37 | $821.5K | 413,563 |
| Mar 13, 2026 | Vivaldi Coelho Rogerio | director | Sell | 5,000 | $36.15 | $180.8K | 16,823 |
| Jan 5, 2026 | Kalofonos Isabel | Chief Commercial Officer | Sell | 2,500 | $55.00 | $137.5K | 0 |
| Dec 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $45.02 | $225.1K | 0 |
| Nov 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $42.66 | $213.3K | 0 |
| Oct 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $41.81 | $209.1K | 0 |
| Sep 26, 2025 | Fust Matthew K | Director | Sell | 16,000 | $44.75 | $716.0K | 0 |
| Sep 26, 2025 | Struthers Richard Scott | President & CEO | Sell | 4,000 | $45.00 | $180.0K | 0 |
| Sep 2, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $32.10 | $160.5K | 0 |
| Aug 22, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 30,000 | $30.43 | $912.9K | 0 |
| Aug 20, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 6,492 | $29.18 | $189.4K | 0 |
| Jun 12, 2025 | Betz Stephen F. | Chief Scientific Officer | Sell | 97,483 | $32.23 | $3.14M | 0 |
| Mar 19, 2025 | Betz Stephen F. | Chief Scientific Officer | Sell | 5,770 | $34.20 | $197.4K | 0 |
| Mar 19, 2025 | Knight Jeff E. | Chief Operating Officer | Sell | 7,162 | $34.20 | $245.0K | 0 |
| Mar 19, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 2,515 | $34.20 | $86.0K | 0 |
| Mar 19, 2025 | Struthers Richard Scott | President & CEO | Sell | 17,338 | $34.20 | $593.0K | 0 |
| Feb 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $39.07 | $195.3K | 0 |
| Jan 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 15,000 | $52.09 | $781.4K | 0 |
| Dec 2, 2024 | Struthers Richard Scott | President & CEO | Sell | 10,000 | $57.57 | $575.7K | 0 |
| Nov 22, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 501 | $56.52 | $28.3K | 0 |
| Oct 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $54.63 | $785.3K | 0 |
| Sep 26, 2024 | Wilson Marc | CFO | Sell | 25,000 | $51.11 | $1.28M | 0 |
| Sep 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 1,035 | $51.50 | $53.3K | 0 |
| Aug 26, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $53.19 | $159.6K | 0 |
| Aug 12, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $47.68 | $143.0K | 0 |
| Jul 25, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $53.43 | $160.3K | 0 |
| Jul 25, 2024 | Wilson Marc | CFO | Sell | 19,056 | $53.88 | $1.03M | 0 |
| Jul 15, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 27,000 | $55.00 | $1.49M | 0 |
| Jul 15, 2024 | Wilson Marc | CFO | Sell | 25,000 | $55.00 | $1.38M | 0 |
| Jul 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $48.55 | $145.7K | 0 |
| Jul 5, 2024 | Hassard James | Chief Commercial Officer | Sell | 15,000 | $44.08 | $661.2K | 0 |
| Jul 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $44.87 | $645.0K | 0 |
| Jun 28, 2024 | Wilson Marc | CFO | Sell | 32,129 | $43.61 | $1.40M | 0 |
| Jun 26, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 956 | $44.38 | $42.4K | 0 |
| Jun 25, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $45.37 | $136.1K | 0 |
| Jun 24, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 9,500 | $45.73 | $434.4K | 0 |
| Jun 21, 2024 | Hassard James | Chief Commercial Officer | Sell | 15,000 | $44.66 | $669.9K | 0 |
| Jun 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $43.86 | $131.6K | 0 |
| May 28, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $47.49 | $142.5K | 0 |
| May 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $49.43 | $148.3K | 0 |
| May 8, 2024 | Struthers Richard Scott | President & CEO | Sell | 107,448 | $49.40 | $5.31M | 0 |
| Apr 15, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $44.47 | $639.3K | 0 |
| Apr 4, 2024 | Struthers Richard Scott | President & CEO | Sell | 40,951 | $49.17 | $2.01M | 0 |
| Mar 28, 2024 | Okey Stephanie | Director | Sell | 17,500 | $46.38 | $811.6K | 0 |
| Mar 22, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 32,359 | $44.31 | $1.43M | 0 |
| Mar 20, 2024 | Fust Matthew K | Director | Sell | 47,500 | $44.28 | $2.10M | 0 |
| Mar 20, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 15,089 | $44.06 | $664.8K | 0 |
Showing 1–50 of 121
1 / 3
CRNX Insider Buying Activity
The following table shows recent insider purchases of Crinetics Pharmaceuticals, Inc. (CRNX) stock reported via SEC Form 4 filings.
No insider buying activity found for CRNX in the last 12 months.
CRNX Insider Selling Activity
The following table shows recent insider sales of Crinetics Pharmaceuticals, Inc. (CRNX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 10, 2026 | Knight Jeff E. | officer: Chief Dev. & Operating Officer | Sell | 85,163 | $40.10 | $3.42M | 105,289-45% |
| Mar 18, 2026 | Betz Stephen F. | officer: Chief Scientific Officer | Sell | 10,612 | $37.37 | $396.6K | 141,342 |
| Mar 18, 2026 | Knight Jeff E. | officer: Chief Operating Officer | Sell | 9,911 | $37.37 | $370.4K | 115,979 |
| Mar 18, 2026 | Struthers Richard Scott | director, officer: President & CEO | Sell | 21,981 | $37.37 | $821.5K | 413,563 |
| Mar 13, 2026 | Vivaldi Coelho Rogerio | director | Sell | 5,000 | $36.15 | $180.8K | 16,823 |
| Jan 5, 2026 | Kalofonos Isabel | Chief Commercial Officer | Sell | 2,500 | $55.00 | $137.5K | 0 |
| Dec 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $45.02 | $225.1K | 0 |
| Nov 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $42.66 | $213.3K | 0 |
| Oct 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $41.81 | $209.1K | 0 |
| Sep 26, 2025 | Fust Matthew K | Director | Sell | 16,000 | $44.75 | $716.0K | 0 |
| Sep 26, 2025 | Struthers Richard Scott | President & CEO | Sell | 4,000 | $45.00 | $180.0K | 0 |
| Sep 2, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $32.10 | $160.5K | 0 |
| Aug 22, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 30,000 | $30.43 | $912.9K | 0 |
| Aug 20, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 6,492 | $29.18 | $189.4K | 0 |
| Jun 12, 2025 | Betz Stephen F. | Chief Scientific Officer | Sell | 97,483 | $32.23 | $3.14M | 0 |
| Mar 19, 2025 | Betz Stephen F. | Chief Scientific Officer | Sell | 5,770 | $34.20 | $197.4K | 0 |
| Mar 19, 2025 | Knight Jeff E. | Chief Operating Officer | Sell | 7,162 | $34.20 | $245.0K | 0 |
| Mar 19, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 2,515 | $34.20 | $86.0K | 0 |
| Mar 19, 2025 | Struthers Richard Scott | President & CEO | Sell | 17,338 | $34.20 | $593.0K | 0 |
| Feb 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $39.07 | $195.3K | 0 |
| Jan 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 15,000 | $52.09 | $781.4K | 0 |
| Dec 2, 2024 | Struthers Richard Scott | President & CEO | Sell | 10,000 | $57.57 | $575.7K | 0 |
| Nov 22, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 501 | $56.52 | $28.3K | 0 |
| Oct 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $54.63 | $785.3K | 0 |
| Sep 26, 2024 | Wilson Marc | CFO | Sell | 25,000 | $51.11 | $1.28M | 0 |
| Sep 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 1,035 | $51.50 | $53.3K | 0 |
| Aug 26, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $53.19 | $159.6K | 0 |
| Aug 12, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $47.68 | $143.0K | 0 |
| Jul 25, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $53.43 | $160.3K | 0 |
| Jul 25, 2024 | Wilson Marc | CFO | Sell | 19,056 | $53.88 | $1.03M | 0 |
| Jul 15, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 27,000 | $55.00 | $1.49M | 0 |
| Jul 15, 2024 | Wilson Marc | CFO | Sell | 25,000 | $55.00 | $1.38M | 0 |
| Jul 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $48.55 | $145.7K | 0 |
| Jul 5, 2024 | Hassard James | Chief Commercial Officer | Sell | 15,000 | $44.08 | $661.2K | 0 |
| Jul 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $44.87 | $645.0K | 0 |
| Jun 28, 2024 | Wilson Marc | CFO | Sell | 32,129 | $43.61 | $1.40M | 0 |
| Jun 26, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 956 | $44.38 | $42.4K | 0 |
| Jun 25, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $45.37 | $136.1K | 0 |
| Jun 24, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 9,500 | $45.73 | $434.4K | 0 |
| Jun 21, 2024 | Hassard James | Chief Commercial Officer | Sell | 15,000 | $44.66 | $669.9K | 0 |
| Jun 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $43.86 | $131.6K | 0 |
| May 28, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $47.49 | $142.5K | 0 |
| May 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $49.43 | $148.3K | 0 |
| May 8, 2024 | Struthers Richard Scott | President & CEO | Sell | 107,448 | $49.40 | $5.31M | 0 |
| Apr 15, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $44.47 | $639.3K | 0 |
| Apr 4, 2024 | Struthers Richard Scott | President & CEO | Sell | 40,951 | $49.17 | $2.01M | 0 |
| Mar 28, 2024 | Okey Stephanie | Director | Sell | 17,500 | $46.38 | $811.6K | 0 |
| Mar 22, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 32,359 | $44.31 | $1.43M | 0 |
| Mar 20, 2024 | Fust Matthew K | Director | Sell | 47,500 | $44.28 | $2.10M | 0 |
| Mar 20, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 15,089 | $44.06 | $664.8K | 0 |
CRNX Insiders
Similar Stocks to CRNX
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B